DE69829662D1 - Vorrichtung und verfahren zur wundbehandlung - Google Patents

Vorrichtung und verfahren zur wundbehandlung

Info

Publication number
DE69829662D1
DE69829662D1 DE69829662T DE69829662T DE69829662D1 DE 69829662 D1 DE69829662 D1 DE 69829662D1 DE 69829662 T DE69829662 T DE 69829662T DE 69829662 T DE69829662 T DE 69829662T DE 69829662 D1 DE69829662 D1 DE 69829662D1
Authority
DE
Germany
Prior art keywords
microspheres
wound healing
composition further
wound treatment
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69829662T
Other languages
English (en)
Other versions
DE69829662T2 (de
Inventor
Vladimir Ritter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polyheal Ltd
Original Assignee
Polyheal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyheal Ltd filed Critical Polyheal Ltd
Application granted granted Critical
Publication of DE69829662D1 publication Critical patent/DE69829662D1/de
Publication of DE69829662T2 publication Critical patent/DE69829662T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
    • B41J2/00—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed
    • B41J2/005—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by bringing liquid or particles selectively into contact with a printing material
    • B41J2/01—Ink jet
    • B41J2/135—Nozzles
    • B41J2/16—Production of nozzles
    • B41J2/1601—Production of bubble jet print heads
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
    • B41J2/00—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed
    • B41J2/005—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by bringing liquid or particles selectively into contact with a printing material
    • B41J2/01—Ink jet
    • B41J2/135—Nozzles
    • B41J2/16—Production of nozzles
    • B41J2/1621—Manufacturing processes
    • B41J2/1623—Manufacturing processes bonding and adhesion
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
    • B41J2/00—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed
    • B41J2/005—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by bringing liquid or particles selectively into contact with a printing material
    • B41J2/01—Ink jet
    • B41J2/135—Nozzles
    • B41J2/16—Production of nozzles
    • B41J2/1621—Manufacturing processes
    • B41J2/164—Manufacturing processes thin film formation
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00—Apparatus or processes for manufacturing printed circuits
    • H05K3/38—Improvement of the adhesion between the insulating substrate and the metal
    • H05K3/386—Improvement of the adhesion between the insulating substrate and the metal by the use of an organic polymeric bonding layer, e.g. adhesive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
    • B41J2/00—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed
    • B41J2/005—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by bringing liquid or particles selectively into contact with a printing material
    • B41J2/01—Ink jet
    • B41J2/135—Nozzles
    • B41J2/14—Structure thereof only for on-demand ink jet heads
    • B41J2002/14362—Assembling elements of heads
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00—Printed circuits
    • H05K1/02—Details
    • H05K1/03—Use of materials for the substrate
    • H05K1/0393—Flexible materials
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00—Apparatus or processes for manufacturing printed circuits
    • H05K3/0058—Laminating printed circuit boards onto other substrates, e.g. metallic substrates
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00—Apparatus or processes for manufacturing printed circuits
    • H05K3/22—Secondary treatment of printed circuits
    • H05K3/28—Applying non-metallic protective coatings
    • H05K3/281—Applying non-metallic protective coatings by means of a preformed insulating foil
DE69829662T 1997-06-04 1998-06-04 Vorrichtung und verfahren zur wundbehandlung Expired - Lifetime DE69829662T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/868,950 US5861149A (en) 1997-06-04 1997-06-04 Methods for wound treatment
US868950 1997-06-04
PCT/IL1998/000260 WO1998055108A1 (en) 1997-06-04 1998-06-04 Device and methods for wound treatment

Publications (2)

Publication Number Publication Date
DE69829662D1 true DE69829662D1 (de) 2005-05-12
DE69829662T2 DE69829662T2 (de) 2006-02-02

Family

ID=25352623

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69829662T Expired - Lifetime DE69829662T2 (de) 1997-06-04 1998-06-04 Vorrichtung und verfahren zur wundbehandlung

Country Status (12)

Country Link
US (2) US5861149A (de)
EP (1) EP0988029B1 (de)
JP (1) JP4594454B2 (de)
KR (1) KR100589064B1 (de)
AT (1) ATE292454T1 (de)
AU (1) AU764113B2 (de)
BR (1) BRPI9809725B1 (de)
CA (1) CA2292528C (de)
DE (1) DE69829662T2 (de)
ES (1) ES2241145T3 (de)
IL (1) IL133162A0 (de)
WO (1) WO1998055108A1 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958148B1 (en) * 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6872384B1 (en) 1998-02-23 2005-03-29 Life Medical Sciences, Inc. Treatment of trauma
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
AU2763099A (en) * 1998-06-22 2000-01-10 Charles E. Worden Enriched platelet wound healant
WO2000024378A1 (en) * 1998-10-23 2000-05-04 Polyheal Ltd Compositions of microspheres for wound healing
US7338657B2 (en) * 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
US6436424B1 (en) * 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
EP1274472A2 (de) 2000-03-20 2003-01-15 Biosphere Medical, Inc. Injizierbare und schwellfähige mikrokügelchen zur gewebeverstärkung
DE01918975T1 (de) * 2000-03-24 2006-04-13 Biosphere Medical, Inc., Rockland Mikrokügelchen zur aktiven Embolisierung
US20030212022A1 (en) * 2001-03-23 2003-11-13 Jean-Marie Vogel Compositions and methods for gene therapy
US6599526B2 (en) * 2000-08-18 2003-07-29 The University Of North Texas Health Science Center At Fort Worth Pericardial anti-adhesion patch
JP2004506688A (ja) * 2000-08-23 2004-03-04 フェアーソン・メディカル・インコーポレーテッド 損傷、および他の適応症の治療
US20030007951A1 (en) * 2000-08-23 2003-01-09 Richard Franklin Treatment of trauma
US7151139B2 (en) * 2001-04-23 2006-12-19 Massachusetts Institute Of Technology Antimicrobial polymeric surfaces
US9089407B2 (en) 2001-04-23 2015-07-28 Massachusetts Institute Of Technology Antibacterial coatings that inhibit biofilm formation on implants
EP1390158A4 (de) * 2001-04-23 2004-06-09 Massachusetts Inst Technology Antimikrobielle polymerflächen
FR2826278B1 (fr) * 2001-06-20 2005-03-25 Lipha Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
ES2207387B1 (es) * 2002-02-28 2005-07-16 Consejo Sup. Investig. Cientificas Composicion quimica de igf-i para el tratamiento y prevencion de enfermedades neurodegenerativas.
KR20050059003A (ko) * 2002-07-02 2005-06-17 프로사이트 코포레이션 펩티드 구리 착화합물 및 연조직 충전제를 함유하는조성물
NZ537735A (en) * 2002-07-03 2006-08-31 Pericor Science Inc Compositions of hyaluronic acid and methods of use
US8016881B2 (en) * 2002-07-31 2011-09-13 Icon Interventional Systems, Inc. Sutures and surgical staples for anastamoses, wound closures, and surgical closures
US20040043947A1 (en) * 2002-08-29 2004-03-04 Gersh Steven A. Methods of treating wounds or ulcers of the foot, ankle or lower extremity of the leg
US7465463B2 (en) * 2002-09-04 2008-12-16 Polyheal, Ltd. Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
WO2004027385A2 (en) * 2002-09-20 2004-04-01 The Children's Hospital Of Philadelphia Engineering of material surfaces
SG2011088127A (en) * 2002-10-25 2015-04-29 Revance Therapeutics Inc Modulation of zinc levels to improve tissue properties
JP2004298556A (ja) * 2003-04-01 2004-10-28 Mitsubishi Rayon Co Ltd 高濃度炭酸温水浴による血管新生療法
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US8663225B2 (en) 2004-11-12 2014-03-04 Medtronic, Inc. Hydrogel bone void filler
EP1690558A1 (de) * 2005-02-11 2006-08-16 NOLabs AB Vorrichtung zur Behandlung von diabetischen Krankheiten
US8221046B2 (en) * 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
US20060193814A1 (en) * 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
US20060193777A1 (en) * 2005-02-25 2006-08-31 Southall Michael D Method of screening compounds for potential efficacy for the treatment of signs of aging
US8278359B2 (en) * 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US20060193818A1 (en) * 2005-02-25 2006-08-31 Southall Michael D Compositions containing amines and use thereof
BRPI0608766A8 (pt) 2005-05-09 2018-04-17 Biosphere Medical Sa microsfera substancialmente esférica, composição, e, métodos para administração de medicamento e para embolização ativa em um mamífero
US20070049739A1 (en) * 2005-08-30 2007-03-01 Biomet Manufacturing Corp. Method and system for extracting blood-derived growth factors
US7547434B2 (en) * 2005-09-09 2009-06-16 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for mitigating skin irritation
US20070092494A1 (en) * 2005-10-26 2007-04-26 Biomet Manufacturing Corp. Composition for wound healing using lyophilized skin or skin-derived collagen
WO2007075853A2 (en) * 2005-12-20 2007-07-05 Swiss-American Products, Inc. Protease compositions for the treatment of damaged tissue
CU23388B6 (es) 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
BRPI0718860A2 (pt) * 2006-11-08 2016-10-04 Massachusetts Inst Technology composição virucida e método para matar vírus
US20090104160A1 (en) * 2007-02-01 2009-04-23 Moraga Biotechnology Corporation Mobilization of Stem Cells After Trauma and Methods Therefor
WO2008139123A2 (fr) * 2007-05-11 2008-11-20 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
EP2155212A2 (de) * 2007-05-11 2010-02-24 Galderma Research & Development Pharmazeutische oder kosmetische präparate zur topischen und/oder parenteralen anwendung, verfahren zu ihrer herstellung und ihre anwendung
WO2009061497A1 (en) * 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US20110244006A1 (en) * 2007-11-29 2011-10-06 The Trustees Of Columbia University In The City Of New York Microsphere skin treatment
US9115180B2 (en) 2008-01-07 2015-08-25 Rapid Pathogen Screening, Inc. Use of peptides for promoting wound healing
MX2010007442A (es) 2008-01-07 2010-12-21 Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg Uso de peptidos para promover la curacion de heridas.
WO2009097561A1 (en) * 2008-01-30 2009-08-06 Doheny Eye Institute Wound closing compounds with additives
WO2009097508A2 (en) * 2008-01-30 2009-08-06 Mcanulty, Jonathan Methods and compositions for wound healing
IL192262A (en) * 2008-06-17 2016-05-31 Z H T Eng Equipment And Tech Ltd A polymer that releases drugs into the animal body, a medicinal product containing it and a method for its preparation
US20100197826A1 (en) * 2009-01-30 2010-08-05 Rajat Agrawal Wound Closing Compounds With Additives
BRPI0900858A2 (pt) * 2009-04-23 2011-05-03 Clinica De Andrologia E Urologia Vera Cruz Ltda composição farmacêutica carreadora de substáncias ativas
WO2011060079A1 (en) * 2009-11-10 2011-05-19 The Trustees Of Columbia University In The City Of New York Compositions and methods for wound treatment
EP2521535B1 (de) 2010-01-05 2018-04-04 Cell Constructs I, Llc Aus menschlichem haar hergestellte biomaterialien
WO2011100425A2 (en) * 2010-02-10 2011-08-18 Wound Engineering Llc Methods and compositions for wound healing
JP5787246B2 (ja) * 2010-09-15 2015-09-30 国立大学法人京都大学 角化細胞遊走・増殖促進剤を含む、創傷治癒剤および褥瘡（床ずれ）治療薬
CN103443272A (zh) 2010-12-27 2013-12-11 智能细胞生物科学有限公司 从脂肪组织获得的源自超声空化的基质或间充质血管提取物和源自其的细胞以及其用途
US20130045269A1 (en) * 2011-08-18 2013-02-21 Sorush LLC Formulations and methods for wound treatment
US8962662B2 (en) 2011-11-15 2015-02-24 Byocoat Enterprises, Inc. Antimicrobial compositions and methods of use thereof
US20130225904A1 (en) * 2012-02-29 2013-08-29 University Of Virginia System and method for magnetic control of an anesthetic
US20130310327A1 (en) 2012-05-18 2013-11-21 Rapid Pathogen Screening, Inc. Histatin for Corneal Wound Healing and Ocular Surface Disease
LT2895209T (lt) 2012-09-13 2019-10-25 Polyheal Ltd Pagerintos žaizdų gydymo kompozicijos, apimančios mikrosferas
MX352455B (es) * 2013-06-28 2017-11-24 Bsn Medical Inc Vendajes ortopédicos de férula y escayola con medio de endurecimiento encapsulado y método.
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
WO2018023021A1 (en) 2016-07-29 2018-02-01 Imbed Biosciences Inc. Methods and compositions for wound healing
JP6456897B2 (ja) 2016-10-05 2019-01-23 マルハニチロ株式会社 抗菌性及び創傷治癒促進性を有する創傷治癒剤
KR101761073B1 (ko) * 2016-11-15 2017-07-25 주식회사 메타바이오메드 폴리펩타이드 금속불활성화제, 이를 이용한 의료용 고분자 화합물 및 그 제조방법
US9993578B1 (en) * 2017-01-12 2018-06-12 Lorstan Pharmaceutical, LLC Silicone oil-in-water composition useful as an injectable filler and as a scaffold for collagen growth
WO2020111743A1 (ko) * 2018-11-26 2020-06-04 한국해양과학기술원 지방 생성을 자극하는 펩타이드, 조성 및 방법

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3842830A (en) * 1973-03-26 1974-10-22 T Hargest Surgical dressing and method of forming the same
US4380855A (en) * 1980-01-18 1983-04-26 University Of Rochester Method for filling hollow shells with gas for use as laser fusion targets
US4273871A (en) * 1980-03-03 1981-06-16 Monsanto Company Production of angiogenic factor by cell culture
DE3312431A1 (de) * 1983-04-07 1984-10-11 B. Braun Melsungen Ag, 3508 Melsungen Pvp-iod-wundpuder mit synergistisch wirkender pudergrundlage
US4772591A (en) * 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
FR2601371B1 (fr) * 1986-07-11 1989-05-12 Merieux Inst Procede de traitement du collagene en vue, notamment, d'en faciliter la reticulation et collagene obtenu par application dudit procede
US4781921A (en) * 1986-10-06 1988-11-01 The University Of Akron Hydrogels of quadrol methacrylate polymers
US4889530A (en) * 1986-10-06 1989-12-26 University Of Akron Wound dressing containing acrylate or methacrylate hydrogel polymer
JPS63160661A (ja) * 1986-12-24 1988-07-04 テルモ株式会社 外用組成物
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5092883A (en) * 1988-12-28 1992-03-03 Eppley Barry L Method for promoting soft connective tissue growth and repair in mammals
FR2648465B1 (fr) * 1989-06-15 1991-09-13 Oreal Procede de preparation de poly (beta)-alanine reticulee, en une seule etape, a partir d'acrylamide et d'un compose polyfonctionnel copolymerisable
FR2649888B1 (fr) * 1989-07-18 1994-08-26 Exsymol Sa Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
AU675206B2 (en) * 1991-09-13 1997-01-30 Gillette Canada Inc. Polymeric particles for dental applications
AU3124793A (en) * 1991-10-29 1993-06-07 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
GB9210574D0 (en) * 1992-05-18 1992-07-01 Ca Nat Research Council Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications
GB9225581D0 (en) * 1992-12-08 1993-01-27 Courtaulds Plc Wound dressings
GB2281861B (en) * 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
US5519020A (en) * 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators

Also Published As

Publication number Publication date
IL133162A0 (en) 2001-03-19
CA2292528C (en) 2007-09-25
US5861149A (en) 1999-01-19
DE69829662T2 (de) 2006-02-02
ATE292454T1 (de) 2005-04-15
BRPI9809725B1 (pt) 2015-12-08
WO1998055108A1 (en) 1998-12-10
CA2292528A1 (en) 1998-12-10
EP0988029A4 (de) 2001-02-21
KR20010013349A (ko) 2001-02-26
BR9809725A (pt) 2001-09-11
AU7671898A (en) 1998-12-21
EP0988029B1 (de) 2005-04-06
ES2241145T3 (es) 2005-10-16
AU764113B2 (en) 2003-08-07
US6086863A (en) 2000-07-11
JP4594454B2 (ja) 2010-12-08
JP2002502413A (ja) 2002-01-22
KR100589064B1 (ko) 2006-06-13
EP0988029A1 (de) 2000-03-29

Similar Documents

Publication Publication Date Title
DE69829662D1 (de) Vorrichtung und verfahren zur wundbehandlung
CA2315115A1 (en) Compositions of microspheres for wound healing
ATE279215T1 (de) Verfahren zur behandlung von organen und gewebe
DE69917625D1 (de) Implantate zur verabreichung von wirkstoffen und verfahren zum herstellen von implantaten
DE69829336D1 (de) Vorrichtung und Verfahren zur Behandlung von Körpergewebe
ATA108689A (de) Vorrichtung und verfahren zur behandlung von medizinischen sonderabfällen
DE69807538D1 (de) Vorrichtung und Verfahren zur Behandlung von Gewebe
DE69428523T2 (de) Verfahren zur behandlung von gemüts- oder geisteskrankheiten und von gemüts- oder geisteskrankheiten, die von anfällen begleitet sind
DE69829625D1 (de) Verfahren und Vorrichtung zur Behandlung von Perfluorokohlenstoff
DE69010893D1 (de) Verfahren zur behandlung von koks sowie löschen desselben.
HK1153377A1 (en) A buprenorphine transdermal patch for use in the treatment of pain for a dosing interval of at least 7 days
DE69726289D1 (de) Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit
ATE342278T1 (de) Verfahren zur behandlung von diabetes mittels kgf
ATE444086T1 (de) Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln
ATE231722T1 (de) Verfahren zur vermeidung von skelettproblemen beim geflügel
DE69422842T2 (de) Verfahren und Einrichtung zur Behandlung von Lithium
DE60006241D1 (de) Verfahren und vorrichtung zur abgabe von viskosem material
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
DE4495520T1 (de) Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen
DE69927154D1 (de) Vorrichtung und verfahren zur behandlung von erektionsstörungen
DE59606907D1 (de) Arzneiform zur abgabe von kollagenase an wunden und verfahren zu ihrer herstellung
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
DE60002469D1 (de) Verfahren und vorrichtung zur abgabe von viskosem material
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: WESTENDORP SOMMER, 80336 MUENCHEN